Literature DB >> 7049350

Reticulum cell sarcomas (large cell lymphomas) presenting in the skin. High frequency of true histiocytic lymphoma.

R Willemze, D J Ruiter, W A Van Vloten, C J Meijer.   

Abstract

The clinical and histologic data from 12 patients with "reticulum cell sarcoma" (large cell lymphoma) presenting in the skin were reviewed. Moreover, when appropriate material was available additional immunological, cytochemical and ultrastructural techniques were used to define the nature of the neoplastic cells. Eight tumors were found to be of true histiocytic origin (histiocytic sarcoma), three of B-cell origin (two B-immunoblastic lymphomas and one centroblastic or large noncleaved follicle center cell lymphoma) and one case could not be classified. Possible explanations for the discrepancy between the current report and other studies as to the frequency of true histiocytic tumors will be discussed. The differentiation into T-cell, B-cell and true histiocytic lymphomas appears to be important, not only because of different clinical behaviour, but possibly also from a therapeutical point of view.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7049350     DOI: 10.1002/1097-0142(19821001)50:7<1367::aid-cncr2820500724>3.0.co;2-4

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

1.  Primary and secondary cutaneous Ki-1+ (CD30+) anaplastic large cell lymphomas. Morphologic, immunohistologic, and clinical-characteristics.

Authors:  P Kaudewitz; H Stein; F Dallenbach; F Eckert; K Bieber; G Burg; O Braun-Falco
Journal:  Am J Pathol       Date:  1989-08       Impact factor: 4.307

2.  Immunocytochemical characterisation of cutaneous lymphomas other than mycosis fungoides.

Authors:  E Ralfkiaer; T A Saati; J Bosq; G Delsol; K C Gatter; D Y Mason
Journal:  J Clin Pathol       Date:  1986-05       Impact factor: 3.411

3.  Lymphomatoid papulosis and Hodgkin's disease: are they related?

Authors:  R Willemze; E Scheffer; W A Van Vloten; C J Meijer
Journal:  Arch Dermatol Res       Date:  1983       Impact factor: 3.017

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.